1-17 of 17
Fateeha Furqan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Split-Dose R-CHOP for Older Patients with Treatment Naïve DLBCL

Adam Kidwell, Fateeha Furqan, Emilie Aschenbrenner, Walter Longo, Sumana Devata, Mehdi Hamadani, Timothy S. Fenske, Nirav N. Shah
Journal: Blood
Blood (2024) 144 (Supplement 1): 2374.
https://doi.org/10.1182/blood-2024-203974
Published: 2024
Journal Articles

Early Safety and Feasibility Results from a Phase II Trial of De-Escalated Ptcy and Ruxolitinib for Gvhd Prophylaxis in Older Patients Undergoing Reduced Intensity Conditioning Allogeneic HCT

Sameem Abedin, Fateeha Furqan, Lyndsey Runaas, Walter Longo, Nirav N. Shah, Timothy S. Fenske, Marcelo C. Pasquini, William R Drobyski, Xue-Zhong Yu, Mehdi Hamadani
Journal: Blood
Blood (2024) 144 (Supplement 1): 1039.
https://doi.org/10.1182/blood-2024-200832
Published: 2024
Journal Articles

Phase II Trial of Axicabagene Ciloleucel and Glofitamab As Second-Line Therapy for Patients with Relapsed or Refractory Large B-Cell Lymphoma

Kunhwa Kim, Dai Chihara, Luis E. Fayad, Sattva S. Neelapu, Sairah Ahmed, Frederick Hagemeister, Chijioke Nze, Swaminathan P Iyer, Preetesh Jain, Michael Wang, Paolo Strati, Fateeha Furqan, Ayushi Chauhan, Michael R. Green, Christopher R. Flowers, Jason R. Westin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4511.1.
https://doi.org/10.1182/blood-2024-205196
Published: 2024
Journal Articles

Retreatment with R-CHOP-like Therapy Is Active with Durable Responses in Patients with Late Relapse of Diffuse Large B-Cell Lymphoma

Eduardo Edelman Saul, Bryan Valcarcel, Amy A. Ayers, Mansoor Noorani, Dai Chihara, Fateeha Furqan, Sairah Ahmed, Swaminathan P Iyer, Sattva S. Neelapu, Luis E. Fayad, F. B. Hagemeister, Chijioke Nze, Preetesh Jain, Michael Wang, Paolo Strati, Ayushi Chauhan, Francisco Vega, Christopher R. Flowers, Jason R. Westin
Journal: Blood
Blood (2024) 144 (Supplement 1): 4454.
https://doi.org/10.1182/blood-2024-211247
Published: 2024
Journal Articles

Engraftment Syndrome during Autologous Stem Cell Transplant in Hodgkin Lymphoma Patients Treated with Checkpoint Inhibitors: A Multi-Center Retrospective Analysis

Eleanor Taranto, Wei-Ting Hwang, Maria Alfaro, Annika S Surapaneni, Sarvarinder Kaur Gill, Tatyana Feldman, Michael P Randall, Michael A Spinner, Fateeha Furqan, Nirav N. Shah, Yazeed Samara, Matthew G. Mei, Alex F. Herrera, Alison Moskowitz, Gunjan L. Shah, Jakub Svoboda
Journal: Blood
Blood (2023) 142 (Supplement 1): 3603.
https://doi.org/10.1182/blood-2023-187199
Published: 2023
Journal Articles

Multicenter Study to Assess the Outcomes and Prognosis of Richter's Transformation in the Era of Novel Agents and Cell Therapy

Fateeha Furqan, Katelin Baird, Merve Kacar, Annika S Surapaneni, Ulrich Kemmo Tsafack, Aniko Szabo, Jakub Svoboda, Brian T. Hill, Jason T. Romancik, Nirav N. Shah
Journal: Blood
Blood (2023) 142 (Supplement 1): 4486.
https://doi.org/10.1182/blood-2023-186703
Published: 2023
Journal Articles

Loncastuximab in High-Risk and Heavily-Pretreated Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Real World Analysis from 21 US Centers

Emily Ayers, Viktoriya Zelikson, Ashwath Gurumurthi, Yazeed Sawalha, Kaitlin Annunzio, Aditi Saha, Ning Dong, David Augustus Qualls, Behzad Amoozgar, Brad S. Kahl, John H. Baird, Pavan Challa, Scott F. Huntington, Jennifer Santos, Steven M. Bair, Mayur S. Narkhede, Shuning Li, Zachary AK Frosch, Carrie I Ho, Stephen D Smith, Allison Winter, Daniel J. Landsburg, Fateeha Furqan, Mehdi Hamadani, Katelin Baird, Jason T. Romancik, Hanan Alharthy, Jennie Law, Leyla Bojanini, Ranjana H. Advani, Boyu Hu, Patrick Connor Johnson, Natalie S. Grover, Debamita Kundu, Mwanasha Hamuza Merrill, Jennifer L Crombie, Nazila Shafagati, Cole Sterling, Loretta J. Nastoupil, Narendranath Epperla
Journal: Blood
Blood (2023) 142 (Supplement 1): 312.
https://doi.org/10.1182/blood-2023-174257
Published: 2023
Journal Articles

Adaptive Manufacturing of LV20.19 CAR T-Cells for Relapsed, Refractory Mantle Cell Lymphoma

Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Tyce Kearl, Anthony Zamora, Jessica Neumann, Parameswaran N. Hari, Dina Schneider, Walter Longo, Peiman Hematti, Bryon D. Johnson, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood
Blood (2023) 142 (Supplement 1): 1024.
https://doi.org/10.1182/blood-2023-173954
Published: 2023
Journal Articles

Single Cell Cytokine Analyses of Bispecific, Tandem, Anti-CD20, Anti-CD19 CAR T-Cells from Patients with Relapsed, Refractory B-Cell Malignancies

Fateeha Furqan, Huiqing Xu, Joanna Zurko, Timothy S. Fenske, Bryon Johnson, Mehdi Hamadani, Nirav N. Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 12690–12691.
https://doi.org/10.1182/blood-2022-169198
Published: 2022
Journal Articles

Results from a Phase 1/2 Study of Tandem, Bispecific Anti-CD20/Anti-CD19 (LV20.19) CAR T-Cells for Mantle Cell Lymphoma

Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Jessica Neumann, Parameswaran Hari, Dina Schneider, Bryon Johnson, Mehdi Hamadani, Timothy S. Fenske
Journal: Blood
Blood (2022) 140 (Supplement 1): 9318–9319.
https://doi.org/10.1182/blood-2022-158695
Published: 2022
Journal Articles

MRD Status By Clonoseq ® Is a Poor Predictor of Long-Term Outcomes after Bispecific LV20.19 CAR T-Cell Therapy for Relapsed, Refractory B-Cell NHL

Fateeha Furqan, Timothy S. Fenske, Walter L. Longo, Bryon Johnson, Mehdi Hamadani, Nirav N. Shah
Journal: Blood
Blood (2022) 140 (Supplement 1): 6407–6408.
https://doi.org/10.1182/blood-2022-170047
Published: 2022
Journal Articles

8-Day Versus 12-Day Manufactured LV20.19 CAR T-Cells for B-Cell Non-Hodgkin Lymphoma

Nirav N. Shah, Fateeha Furqan, Aniko Szabo, Jessica Neumann, Walter L. Longo, Parameswaran Hari, Dina Schneider, Bryon Johnson, Timothy S. Fenske, Mehdi Hamadani
Journal: Blood
Blood (2022) 140 (Supplement 1): 7480–7481.
https://doi.org/10.1182/blood-2022-169119
Published: 2022
Journal Articles

Prognostic impact of corticosteroids on efficacy of chimeric antigen receptor T-cell therapy in large B-cell lymphoma

Brief Report
Paolo Strati, Sairah Ahmed, Fateeha Furqan, Luis E. Fayad, Hun J. Lee, Swaminathan P. Iyer, Ranjit Nair, Loretta J. Nastoupil, Simrit Parmar, Maria A. Rodriguez, Felipe Samaniego, Raphael E. Steiner, Michael Wang, Chelsea C. Pinnix, Sandra B. Horowitz, Lei Feng, Ryan Sun, Catherine M. Claussen, Misha C. Hawkins, Nicole A. Johnson, Prachee Singh, Haleigh Mistry, Swapna Johncy, Sherry Adkins, Partow Kebriaei, Elizabeth J. Shpall, Michael R. Green, Christopher R. Flowers, Jason Westin, Sattva S. Neelapu
Journal: Blood
Blood (2021) 137 (23): 3272–3276.
https://doi.org/10.1182/blood.2020008865
Published: 2021
Includes: Supplemental data
Journal Articles

Multiple Myeloma: Where Do We Lose Ground Along the Treatment Pathway?

Dharmini Manogna, MD, Bassil Said, MD, Naman Sharma, MD, Fateeha Furqan, MD, Jonathan Bress, MD MS, Saad Jamshed, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-141593
Published: 2020
Journal Articles

Congenital FVIII/IX or VWF Deficiency Does Confer a Lower Rate of Myocardial Infarction-Related Mortality Despite Decreased Cardiovascular Interventions

Fateeha Furqan, MD, Nicolas Goldstein, Peter A. Kouides, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 1120.
https://doi.org/10.1182/blood-2019-131387
Published: 2019
Journal Articles

Efficacy of Fecal Microbiota Transplant in Hematological Cancers Patients with Recurrent Clostridioides Difficile Infection: A Systemic Review and Meta-Analysis

Raseen Tariq, MBBS, Fateeha Furqan, MD, Saad Jamshed, MD, Sahil Khanna, MBBS
Journal: Blood
Blood (2019) 134 (Supplement_1): 5870.
https://doi.org/10.1182/blood-2019-131431
Published: 2019
Journal Articles

Risk Factors of Clostridium Difficile Infection in Hematopoietic Stem Cell Transplant Recipients: A Systemic Review and Meta-Analysis

Raseen Tariq, MBBS, Fateeha Furqan, MD, Saad Jamshed, MD, Sahil Khanna, MBBS
Journal: Blood
Blood (2018) 132 (Supplement 1): 4704.
https://doi.org/10.1182/blood-2018-99-114231
Published: 2018